Updated:
Institut Pasteur
The Institut Pasteur was founded in 1887. It functions as a not-for-profit private foundation dedicated to biomedical research. The foundation pursues...
Institut Pasteur
The Institut Pasteur was founded in 1887. It functions as a not-for-profit private foundation dedicated to biomedical research. The foundation pursues early-stage venture investments in biotechnology. Confirmed holdings include Eligo Bioscience, PathoQuest and Enodia Therapeutics through Pasteur Innovation. It also holds positions in Cellectis and maintains a strategic relationship with Sanofi. Activity centers on France with additional reach through the Pasteur Network across multiple continents. The organization reports 2,780 professionals. It operates the Fonds de Dotation de l'Institut Pasteur to manage long-term assets. In October 2024 it participated as a speaker at the World Health Summit in Berlin. Governance centers on its status as a private foundation with an Ethics Charter. This structure separates research operations from endowment management through dedicated vehicles.
General information
Firm type
Endowment / Foundation
Year founded
1887
Location
Region
Europe
Country
France
City
Paris
Corporate office
25-28 Rue du Docteur Roux, 75015 Paris, France
Sector focus
Frequently asked questions
Who runs investment decisions at Institut Pasteur?
Investment activity occurs through Pasteur Innovation and the Fonds de Dotation. No individual portfolio managers are named in public records.
Does Institut Pasteur participate in fund commitments or only direct deals?
It holds direct positions in startups including Eligo Bioscience and DNA Script. It also acts as limited partner in Argobio Studio.
What investment stages does Institut Pasteur typically target?
Activity centers on early-stage and seed investments in biotechnology companies based in France.
How is Institut Pasteur related to Sanofi?
It maintains a long-standing strategic alliance for vaccine development and holds historical shareholdings with ongoing royalty agreements.
Where does the underlying wealth come from?
The foundation was established in 1887 by Louis Pasteur. No specific family wealth origin is disclosed beyond its founding charter.
Does Institut Pasteur maintain philanthropic structures, and how are they separated?
It operates the Fonds de Dotation de l'Institut Pasteur to manage endowment assets separately from research operations.
What is Institut Pasteur's known posture on co-investments alongside external GPs?
It collaborates with partners including the Bill & Melinda Gates Foundation on global health initiatives and with Bpifrance on strategic investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: